Skip to content

ERNIE4: Urine and CRP Point-of-care Test in Acutely Ill Children

Urine and CRP Tests at the Point-of-care for the Diagnostic Assessment of Acutely Ill Children: a Diagnostic and Prognostic Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03835104
Acronym
ERNIE4
Enrollment
868
Registered
2019-02-08
Start date
2019-02-12
Completion date
2020-05-22
Last updated
2021-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection

Keywords

diagnosis, sensitivity and specificity, serious infections

Brief summary

This study aims to assess the accuracy of a novel urine test for diagnosing urinary tract infections in acutely ill children presenting to ambulatory care. The accuracy of this novel test will be compared to the accuracy of conventional dipstick testing. In addition, the evidence on urine tests will be added to the existing algorithm for diagnosing serious infections in children. Finally, the study aims to describe the relation between the CRP level at study entry and the duration of symptoms and final diagnosis over the following 30 days.

Detailed description

The design is a cross-sectional cohort study with a nested longitudinal follow-up in acutely children presenting to ambulatory care. The cross-sectional cohort study will compare an innovative urine test with conventional dipstick testing to establish their relative accuracy to diagnose urinary tract infections, and construct an algorithm consisting of clinical features, urine test results and CRP point-of-care testing to identify serious infections. The longitudinal follow-up study will describe illness trajectories of children with an intermediate CRP test result (5-80 mg/L) at first contact. The study will run in general practices and community paediatrics in Flanders. Recruitment to the study is expected to last 18 months, with each patient entering the study only once. Children and their parents/guardians will be approached for possible participation in the study by practice staff. There is only one study visit. Those who agree to participation via written informed consent will have demographics and clinical features recorded. All children will be asked to provide a urine sample on study entry. Subsequently, CRP point-of-care testing will be conducted in all children testing positive on a clinical prediction rule, and in a random sample of children testing negative on that rule. Follow-up information for all children will be collected using general practice notes, hospital records and direct patient/parent contact. Treatment and other management decisions will be left to the treating physicians' discretion.

Interventions

DEVICECRP point-of-care testing

CRP point-of-care test using a fingerprick of blood and producing a result within 4 minutes, using the Afinion 2 (Abbott)

Sponsors

KU Leuven
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

The study is a cluster randomized controlled trial. The general practice is the unit of cluster.

Eligibility

Sex/Gender
ALL
Age
3 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Aged 3 months to 18 years * Presenting to a general practice or community paediatrics * Acute illness of a maximum of 10 days * Parent or guardian is willing and able to give informed consent for participation

Exclusion criteria

* Clinically unstable warranting immediate care * Urinary catheter in situ * Immunosuppressant medication taken in the previous 30 days * Trauma is the main presenting problem * Antibiotics taken in the previous 7 days * Children who present to community paediatrics as a result of direct GP referral

Design outcomes

Primary

MeasureTime frameDescription
Urinary tract infection3 daysThe number of children with a urinary tract infection based on urine culture

Secondary

MeasureTime frameDescription
Serious infections30 daysThe number of children admitted to hospital for a serious infection which can be pneumonia, sepsis, meningitis, pyelonephritis, osteomyelitis or appendicitis

Other

MeasureTime frameDescription
Final diagnosis30 daysFor children not admitted to hospital, the final diagnosis based on all available clinical information from ambulatory care assessment over 30 days after the index date.
Duration of symptoms30 daysFor all children, the duration of symptoms after the index date based on patient diaries
Healthcare resource use30 daysFor all children, re-consultation rates in ambulatory care after the index date

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026